ForteBio

Menlo Park, United States Founded: 2001 • Age: 25 yrs Acquired By Pall
Real-time biomolecular interactions are analyzed using specialized instruments.
Request Access

About ForteBio

ForteBio is a company based in Menlo Park (United States) founded in 2001 was acquired by Pall in December 2011.. ForteBio has raised $42.3 million across 2 funding rounds from investors including Orbimed, Pall and Turmeric Acquisition Corp. ForteBio operates in a competitive market with competitors including Creoptix, Gator Bio and Biacore, among others.

  • Headquarter Menlo Park, United States
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $42.3 M (USD)

    in 2 rounds

  • Latest Funding Round
    $25 M (USD), Series C

    Sep 23, 2008

  • Investors
    Orbimed

    & 6 more

  • Employee Count
    Employee Count
  • Acquired by
    Pall

    (Dec 19, 2011)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of ForteBio

ForteBio has successfully raised a total of $42.3M across 2 strategic funding rounds. The most recent funding activity was a Series C round of $25 million completed in September 2008. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 2
  • Last Round Series C — $25.0M
  • First Round

    (26 Oct 2005)

  • Investors Count 6
Date Amount Transaction Name Valuation Lead Investors Investors
Sep, 2008 Amount Series C - ForteBio Valuation

investors

Oct, 2005 Amount Series B - ForteBio Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in ForteBio

ForteBio has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include Orbimed, Pall and Turmeric Acquisition Corp. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Investments are made by OrbiMed in global healthcare innovations across biopharmaceuticals and related fields.
Founded Year Domain Location
Early stage venture capital firm investing in the US
Founded Year Domain Location
Early-stage healthcare startups are supported with venture capital.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by ForteBio

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - ForteBio

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Fortebio Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of ForteBio

ForteBio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Creoptix, Gator Bio and Biacore, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Instruments for high-sensitivity label-free molecular interactions analysis are developed.
domain founded_year HQ Location
Creates innovative technologies for biomolecular detection.
domain founded_year HQ Location
Instrument systems for label-free molecular interaction analysis are developed.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Fortebio

Frequently Asked Questions about ForteBio

When was ForteBio founded?

ForteBio was founded in 2001 and raised its 1st funding round 4 years after it was founded.

Where is ForteBio located?

ForteBio is headquartered in Menlo Park, United States. It is registered at Menlo Park, California, United States.

Is ForteBio a funded company?

ForteBio is a funded company, having raised a total of $42.3M across 2 funding rounds to date. The company's 1st funding round was a Series B of $17.3M, raised on Oct 26, 2005.

What does ForteBio do?

ForteBio develops instruments for the real-time analysis of biomolecular interactions based on the companys proprietary Bio-Layer Interferometry (BLI) techology - a label-free optical analysis method that measures biomolecular interactions by the changes in the interference pattern of white light reflected from two surfaces (a layer of immobilized protein on the biosensor tip, and an internal reference layer) due to changes in the number of molecules binding to the biosensor tip. The change in interference pattern can be measured in real time. Since only the molecules binding to the biosensor tip contribute to the change in interference patterns, and hence the signal, the system can be used to generate highly specific data from complex mixtures. The company has four main product lines. The Octet range is the all-inclusive instrumentation, reagent and assay-integrated system that enables the study of protein-protein interactions in 96 and 384 well plates. The Blitz product range enables label-free cell analysis for single researchers and standalone labs. In addition, it also manufactures the Dip and Read biosensors and assays, and the Ready BLI assay range. In Dec 2011, Pall acquired ForteBio for an undisclosed sum.

Who are the top competitors of ForteBio?

ForteBio's top competitors include Creoptix, Biacore and Gator Bio.

Who are ForteBio's investors?

ForteBio has 7 investors. Key investors include Orbimed, Pall, Turmeric Acquisition Corp, Alloy Ventures, and Latterell Venture Partners.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available